Profile
Full Name
Kalaris Therapeutics, Inc.Ticker Symbol
KLRSExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 30, 2020Indexes
Not includedWebsite
http://kalaristx.comEmployees
14Key Details
Price
$7.23(-1.09%)
Market cap
$135.22M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.79(+5.08% YoY)
PE ratio
-
Next earnings date
N/ANext ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Kalaris Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 8, 25 William Blair
OutperformInstitutional Ownership
- What is the ticker symbol for Kalaris Therapeutics?
- Does Kalaris Therapeutics pay dividends?
- What sector is Kalaris Therapeutics in?
- What industry is Kalaris Therapeutics in?
- What country is Kalaris Therapeutics based in?
- When did Kalaris Therapeutics go public?
- Is Kalaris Therapeutics in the S&P 500?
- Is Kalaris Therapeutics in the NASDAQ 100?
- Is Kalaris Therapeutics in the Dow Jones?
- When does Kalaris Therapeutics report earnings?
- Should I buy Kalaris Therapeutics stock now?
What is the ticker symbol for Kalaris Therapeutics?
The ticker symbol for Kalaris Therapeutics is NASDAQ:KLRS
Does Kalaris Therapeutics pay dividends?
No, Kalaris Therapeutics does not pay dividends
What sector is Kalaris Therapeutics in?
Kalaris Therapeutics is in the Healthcare sector
What industry is Kalaris Therapeutics in?
Kalaris Therapeutics is in the Biotechnology industry
What country is Kalaris Therapeutics based in?
Kalaris Therapeutics is headquartered in United States
When did Kalaris Therapeutics go public?
Kalaris Therapeutics's initial public offering (IPO) was on July 30, 2020
Is Kalaris Therapeutics in the S&P 500?
No, Kalaris Therapeutics is not included in the S&P 500 index
Is Kalaris Therapeutics in the NASDAQ 100?
No, Kalaris Therapeutics is not included in the NASDAQ 100 index
Is Kalaris Therapeutics in the Dow Jones?
No, Kalaris Therapeutics is not included in the Dow Jones index
When does Kalaris Therapeutics report earnings?
The date for Kalaris Therapeutics's next earnings report has not been announced yet
Should I buy Kalaris Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions